SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and …

M Smadi, M Kaburis, Y Schnapper, G Reina… - The British Journal of …, 2023 - cambridge.org
BackgroundPeople with neurodegenerative disease and mild cognitive impairment (MCI)
may have an elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic

AD Nawaz, MZ Haider, S Akhtar - Biomolecules and Biomedicine, 2024 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection initially results in
respiratory distress symptoms but can also lead to central nervous system (CNS) and …

Association between COVID-19 vaccination and critical outcomes among older adults with dementia: a comparative cohort study

Z Radomyslsky, S Kivity, S Lidar, N Bentur… - Frontiers in Public …, 2023 - frontiersin.org
Background As COVID-19 vaccines became available, understanding their potential
benefits in vulnerable populations has gained significance. This study explored the …

COVID‐19 outcomes among patients with dementia and age‐matched controls who were hospitalized in 21 US health‐care systems

AL Johnson, NA Chin, TM Piasecki… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION COVID‐19 had devastating impacts worldwide. However, most research
examining the impact of dementia on COVID‐19 outcomes has been conducted in Europe …